lobbying_activities: 1162451
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1162451 | b70aa75d-d846-471d-a40e-6c529cc35d4a | Q3 | KNIGHT CAPITOL CONSULTANTS | 40036301 | GENZYME CORPORATION | 2011 | third_quarter | PHA | S. 606, Creating Hope Act of 2011 S. 296/H.R. 2245, Preserving Access to Life-Saving Medication Act Reauthorization of the Prescription Drug User Fee Act and possible amendments thereto (no legislation yet) | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-10-19T19:42:32.737000-04:00 |